Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

VX135 + Ribavirin: Enrollment in one study is

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
jq1234 Member Profile
Member Level 
Followed By 48
Posts 3,836
Boards Moderated 0
Alias Born 12/13/09
160x600 placeholder
Royal Bank of Scotland says it set aside $640 million to cover potential fines for the alleged manipulation of foreign-exchange rates, as the British bank swung to a third-quarter net profit.
More Top Equities Stories Of The Day
European Markets Show Signs of Stress--2nd Update
ADR Shares End Mixed; Sanofi, Banco Bilbao Vizcaya Argentaria Shares Fall
Shire Files 8K - Other Events
Apple CEO Says He's 'Proud to Be Gay'
U.S. Stocks, Bonds Dip on Fed Outlook
Stoxx 600 Flirts With Three-week High
FTSE 100 Ends Higher After Roller-coaster Day
European Stocks Climb For Third Straight Day
jq1234 Member Level  Tuesday, 04/30/13 06:49:53 PM
Re: DewDiligence post# 160555
Post # of 183388 
VX135 + Ribavirin: Enrollment in one study is complete, expect data 2nd half this year. I suppose most likely at AASLD in Nov.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist